Figures & data
Figure 1 MiR-99a is downregulated in NPC cell lines and clinical specimens.
Abbreviation: NPC, nasopharyngeal carcinoma.
![Figure 1 MiR-99a is downregulated in NPC cell lines and clinical specimens.](/cms/asset/8f466deb-8bbd-421a-af89-d498f002adb2/dott_a_126781_f0001_c.jpg)
Figure 2 Overexpression of miR-99a inhibits nasopharyngeal carcinoma cell migration and invasion in vitro.
![Figure 2 Overexpression of miR-99a inhibits nasopharyngeal carcinoma cell migration and invasion in vitro.](/cms/asset/bb8b835b-4aa7-4b16-936d-832812fddd1b/dott_a_126781_f0002_c.jpg)
Figure 3 Silencing of miR-99a promotes nasopharyngeal carcinoma cell migration and invasion in vitro.
![Figure 3 Silencing of miR-99a promotes nasopharyngeal carcinoma cell migration and invasion in vitro.](/cms/asset/04395e2a-5b1a-4395-be71-843d8ce8294d/dott_a_126781_f0003_c.jpg)
Figure 4 Overexpression of miR-99a suppresses nasopharyngeal carcinoma lung metastasis in vivo.
![Figure 4 Overexpression of miR-99a suppresses nasopharyngeal carcinoma lung metastasis in vivo.](/cms/asset/af4fd1f2-3e40-45de-bd9e-e0a0d39df646/dott_a_126781_f0004_c.jpg)
Figure 5 HOXA1 is a direct target of miR-99a in nasopharyngeal carcinoma.
Abbreviations: RT-PCR, reverse transcriptase polymerase chain reaction; 3′-UTR, 3′-untranslated region; CMV, cytomegalovirus; WT, wild-type; MT, mutant type.
![Figure 5 HOXA1 is a direct target of miR-99a in nasopharyngeal carcinoma.](/cms/asset/6210d77b-014e-41b1-bef6-37936768d9c1/dott_a_126781_f0005_c.jpg)
Figure 6 HOXA1 is involved in miR-99a-mediated nasopharyngeal carcinoma cell migration and invasion.
![Figure 6 HOXA1 is involved in miR-99a-mediated nasopharyngeal carcinoma cell migration and invasion.](/cms/asset/d771e9f8-3253-4b93-a315-5b507a437c57/dott_a_126781_f0006_c.jpg)